×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by ZANTE GREG

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerOct 28, 2024Option Exercise$7.4994,001704,282281,053Oct 28, 2024, 09:48 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerOct 28, 2024Sale$76.61131,68710,089,164231,381Oct 28, 2024, 09:48 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJul 30, 2024Sale$57.1516,136922,212190,526Jul 31, 2024, 04:05 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerMay 03, 2024Sale$74.6966,7564,986,008238,509May 03, 2024, 08:51 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerMay 03, 2024Option Exercise$4.8634,249166,285241,610May 03, 2024, 08:51 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerMar 27, 2024Option Exercise$83.3416,6101,384,277207,361Mar 27, 2024, 08:50 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerMar 01, 2024Option Exercise$85.2220,0931,712,325192,304Mar 04, 2024, 07:50 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 03, 2024Option Exercise$17.4049,122854,723209,602Jan 04, 2024, 09:35 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 04, 2024Option Exercise$18.5813,872257,742195,730Jan 04, 2024, 09:35 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 04, 2024Sale$17.9015,000268,500180,730Jan 04, 2024, 09:35 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 17, 2023Option Exercise$13.077,50098,025156,779Apr 18, 2023, 07:07 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 17, 2023Sale$20.007,500150,000149,279Apr 18, 2023, 07:07 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 11, 2023Sale$18.0056,2951,013,518149,279Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 12, 2023Option Exercise$5.9941,544249,026190,823Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 12, 2023Sale$18.0041,544747,792149,279Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 11, 2023Option Exercise$5.2556,295295,778205,574Apr 13, 2023, 05:13 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerMar 30, 2023Sale$17.00131,0292,227,821147,778Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 03, 2023Option Exercise$17.5755,166969,267149,279Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 03, 2023Option Exercise$7.7730,911240,178178,689Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerApr 03, 2023Sale$18.0030,911556,398147,778Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerMar 30, 2023Option Exercise$7.2993,750683,483278,807Apr 03, 2023, 07:24 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerDec 30, 2022Option Exercise$9.4019,697185,152139,031Jan 04, 2023, 06:25 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 03, 2023Option Exercise$8.5223,933203,909205,765Jan 04, 2023, 06:25 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 04, 2023Option Exercise$8.4220,708174,361185,057Jan 04, 2023, 06:25 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 03, 2022Option Exercise$4.883,09715,11391,806Jan 05, 2022, 07:13 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 04, 2022Option Exercise$4.628,83540,818136,304Jan 05, 2022, 07:13 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerSep 28, 2021Option Exercise$6.502,30614,98994,485Sep 30, 2021, 05:43 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 19, 2021Option Exercise$6.688085,39789,751Jan 19, 2021, 06:25 PM
VKTXViking Therapeutics, Inc.ZANTE GREGChief Financial OfficerJan 04, 2021Option Exercise$5.802,78716,16590,559Jan 06, 2021, 04:28 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe